A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 14, Issue 3, 2013, Pages 235-241

  Zhou, Tian Biao ^a   Yin, Sheng Sheng ^a,b   Liang, Rong ^c  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI UNIVERSITY FOR NATIONALITIES   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

angiotensin converting enzyme; End stage renal disease; IgA nephropathy; insertion deletion gene polymorphism; meta analysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; ASIAN; CAUCASIAN; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INDEL MUTATION; KIDNEY FAILURE; META ANALYSIS;

ANGIOTENSIN-CONVERTING ENZYME; END-STAGE RENAL DISEASE; IGA NEPHROPATHY; INSERTION/DELETION GENE POLYMORPHISM; META-ANALYSIS;

ALLELES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; INDEL MUTATION; KIDNEY FAILURE, CHRONIC; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK FACTORS;

EID: 84883016842     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312459978     Document Type: Article

References (37)

1. Rosselli JL, Thacker SM, Karpinski JP, et al. Treatment of IgA nephropathy: An update. Ann Pharmacother. 2011 ; 45: 1284-1296
2. Marson BP, de Figueiredo CE, Tanus-Santos JE. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: A potential pharmacological target. Basic Clin Pharmacol Toxicol. 2012 ; 110: 409-415
3. Trabulus S, Guven GS, Altiparmak MR, et al. DNA repair XRCC1 Arg399Gln polymorphism is associated with the risk of development of end-stage renal disease. Mol Biol Rep. 2012 ; 39: 6995-7001
4. Cheng W, Zhou X, Zhu L, et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese. Nephrol Dial Transplant. 2011 ; 26: 2544-2549
5. Gorgi Y, Hbibi I, Sfar I, et al. Role of genetic polymorphisms in factor H and MBL genes in Tunisian patients with immunoglobulin A nephropathy. Int J Nephrol Renovasc Dis. 2010 ; 3: 27-32
6. Watanabe Y, Inoue T, Okada H, et al. Impact of selectin gene polymorphisms on rapid progression to end-stage renal disease in patients with IgA nephropathy. Intern Med. 2006 ; 45: 947-951
7. Berthoux FC, Berthoux P, Mariat C, et al. CC-chemokine receptor five gene polymorphism in primary IgA nephropathy: The 32 bp deletion allele is associated with late progression to end-stage renal failure with dialysis. Kidney Int. 2006 ; 69: 565-572
8. Tronvik E, Stovner LJ, Bovim G, et al. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients. BMC Neurol. 2008 ; 8: 4
9. Yaren A, Oztop I, Turgut S, et al. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Exp Biol Med (Maywood). 2008 ; 233: 32-37
10. Bonnet F, Patel S, Laville M, et al. Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care. 2008 ; 31: 789-794
11. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994 ; 50: 1088-1101
12. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 ; 315: 629-634
13. Huang HD, Lin FJ, Li XJ, et al. Genetic polymorphisms of the renin-angiotensin-aldosterone system in Chinese patients with end-stage renal disease secondary to IgA nephropathy. Chin Med J (Engl). 2010 ; 123: 3238-3242
14. Lau YK, Woo KT, Choong HL, et al. ACE gene polymorphism and disease progression of IgA nephropathy in Asians in Singapore. Nephron. 2002 ; 91: 499-503
15. Lau YK, Woo KT, Choong HL, et al. Renin-angiotensin system gene polymorphisms: Its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore. Nephron Physiol. 2004 ; 97: 1-8
16. Ong-Ajyooth S, Ong-Ajyooth L, Limmongkon A, et al. The renin-angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy. J Med Assoc Thai. 1999 ; 82: 681-689
17. Suzuki S, Suzuki Y, Kobayashi Y, et al. Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy. Am J Kidney Dis. 2000 ; 35: 896-903
18. Woo KT, Chan CM, Choong HL, et al. High dose Losartan and ACE gene polymorphism in IgA nephritis. Genomic Med. 2008 ; 2: 83-91
19. Woo KT, Lau YK, Chan CM, et al. ACE gene sequence and nucleotide variants in IgA nephropathy. Singapore Med J. 2011 ; 52: 824-834
20. Xu F, Lv Y, Shao R, et al. Investigation on the association of angiotensin-converting enzyme gene polymorphism with IgA nephropathy risk. Chinese Journal of Integrated Traditional and Western Nephrology. 2001 ; 2: 95-96
21. Yoshida H, Mitarai T, Kawamura T, et al. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest. 1995 ; 96: 2162-2169
22. Zheng X, Zhang Y, Li X, et al. Relationship between angiotensin- converting enzyme insertion/deletion gene polymorphism and IgA nephropathy risk. Chinese Journal of Nephrology. 1999 ; 15: 379-380
23. Woo KT, Lau YK, Zhao Y, et al. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis. Cell Mol Immunol. 2007 ; 4: 227-232
24. Schmidt S, Stier E, Hartung R, et al. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis. 1995 ; 26: 727-731
25. Hunley TE, Julian BA, Phillips JR, et al. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int. 1996 ; 49: 571-577
26. Zhou TB, Ou C, Qin YH, et al. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and Henoch-Schönlein purpura nephritis risk in Asian children. Clin Exp Rheumatol. 2012 ; 30: 315-316
27. Yu ZY, Chen LS, Zhang LC, et al. A meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology (Carlton). 2012 ; 17: 480-487
28. Zhou TB, Ou C, Qin YH, et al. Association of angiotensin converting enzyme insertion/deletion gene polymorphism with idiopathic nephrotic syndrome susceptibility in children: A meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011 ; 12: 601-610
29. Zhou TB, Qin YH, Su LN, et al. Insertion/deletion (I/D) polymorphism of angiotensin-converting enzyme gene in steroid-resistant nephrotic syndrome for children: A genetic association study and meta-analysis. Ren Fail. 2011 ; 33: 741-748
30. Zhou TB, Qin YH, Su LN, et al. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: A systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst. 2011 ; 12: 624-633
31. Wiwanitkit V. Angiotensin-converting enzyme gene polymorphism is correlated to the progression of disease in patients with IgA nephropathy: A meta-analysis. Ren Fail. 2006 ; 28: 697-699
32. Pereira TV, Nunes AC, Rudnicki M, et al. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: A meta-analysis. Nephrol Dial Transplant. 2006 ; 21: 3155-3163
33. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001 ; 345: 861-869
34. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001 ; 345: 851-860
35. Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006 ; 354: 131-140
36. Lee SE, Kim YJ, Lee HY, et al. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): A 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension. Clin Ther. 2012 ; 34: 552-568
37. Ma TK, Szeto CC. Mineralocorticoid receptor antagonist for renal protection. Ren Fail. 2012 ; 34: 810-817